The Connection Between Aminoglycosides-Induced Kidney Injury and SMN1 Gene Function

By SWA

Aminoglycosides are a class of antibiotics frequently used to treat severe bacterial infections, especially those caused by Gram-negative bacteria.
Despite their effectiveness, aminoglycosides are notorious for their nephrotoxic (kidney-damaging) and ototoxic (ear-damaging) side effects. On the other hand, the SMN1 (Survival Motor Neuron 1) gene is primarily known for its role in spinal muscular atrophy (SMA), a genetic disorder characterized by motor neuron degeneration. Although the connection between aminoglycoside-induced kidney injury and SMN1 is not immediately obvious, recent studies suggest a possible interplay of cellular stress and genetic vulnerability, which may exacerbate nephrotoxicity, particularly in individuals with compromised SMN1 function.

Understanding Aminoglycoside Nephrotoxicity

Aminoglycosides, such as gentamicin, tobramycin, and amikacin, are highly effective antibiotics; however, their use is limited due to their potential to cause kidney injury. The mechanism of aminoglycoside-induced nephrotoxicity primarily involves oxidative stress, mitochondrial dysfunction, and disruption of cellular homeostasis within renal tubular cells. These antibiotics are taken up by proximal tubular cells in the kidney, where they accumulate and induce cellular damage through reactive oxygen species (ROS) production and impaired energy metabolism.

Reference: Kashiwagi, T., Okuno, Y., Ikawa, K., & Morikawa, N. (2021). Aminoglycoside-induced nephrotoxicity: molecular mechanisms and prevention strategies. Journal of Clinical and Experimental Nephrology. PubMed

The Role of SMN1 in Cellular Function

The SMN1 gene encodes the Survival Motor Neuron (SMN) protein, which is essential for the biogenesis of small nuclear ribonucleoproteins (snRNPs) and the proper functioning of the spliceosome, a complex critical for RNA processing. SMN protein is not only crucial in neurons but also plays a significant role in the general maintenance of cellular integrity across various tissues, including the kidneys.

Individuals with mutations in SMN1, such as those seen in spinal muscular atrophy (SMA), have reduced SMN protein levels, leading to impaired cellular functions, particularly in neurons. However, the impact extends beyond the nervous system, potentially making other tissues, like the kidneys, more susceptible to damage when exposed to nephrotoxic agents.

Reference: Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., & Munnich, A. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80(1), 155-165. ScienceDirect

Genetic Modifiers in Drug-Induced Toxicity

Genetic variations can significantly influence an individual’s susceptibility to drug-induced toxicities, including aminoglycoside nephrotoxicity. For instance, variations in genes involved in oxidative stress responses, mitochondrial function, and cellular repair can modify the severity of aminoglycoside-induced damage. Although direct studies linking SMN1 mutations to heightened aminoglycoside toxicity are limited, there is a growing body of evidence suggesting that SMN1 mutations, by compromising cellular homeostasis, could amplify the nephrotoxic effects of these antibiotics.

Reference: Relling, M. V., & Evans, W. E. (2015). Pharmacogenomics in the clinic. Nature, 526(7573), 343-350. Nature

Oxidative Stress and Cellular Vulnerability in SMA

Individuals with reduced SMN protein levels, such as those with SMA, often exhibit increased oxidative stress and impaired mitochondrial function, which can predispose them to greater vulnerability to nephrotoxic agents. The kidney cells' ability to manage oxidative damage is compromised, creating a scenario where aminoglycosides can cause more severe injury than in individuals with normal SMN1 function.

Reference: Tisdale, S., Lotti, F., Saieva, L., Van Meerbeke, J. P., Crawford, T. O., Sumner, C. J., & Pellizzoni, L. (2013). SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3′-end formation of histone mRNAs. Cell Reports, 5(5), 1187-1195. ScienceDirect

Nephrotoxic Mechanisms of Aminoglycosides

The primary mechanism through which aminoglycosides induce nephrotoxicity involves the drug's accumulation in renal proximal tubule cells, where it disrupts protein synthesis, alters cellular metabolism, and triggers apoptosis. The generation of reactive oxygen species further exacerbates cellular damage, leading to functional impairment of the kidneys. These effects are especially pronounced in cells that are already vulnerable due to underlying genetic mutations or deficiencies, such as those seen with reduced SMN protein.

Reference: Lopez-Novoa, J. M., Quiros, Y., Vicente, L., Morales, A. I., & Lopez-Hernandez, F. J. (2011). New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney International, 79(1), 33-45. PubMed

Conclusion

While the direct connection between aminoglycoside-induced kidney injury and the SMN1 gene may not be fully understood, there is significant evidence that genetic factors, such as reduced SMN protein levels, can exacerbate the nephrotoxic effects of aminoglycosides. This highlights the importance of considering genetic background when evaluating the risks associated with aminoglycoside therapy, particularly in vulnerable populations. Future research is needed to further elucidate the molecular mechanisms linking SMN1 dysfunction with heightened susceptibility to drug-induced kidney injury and to develop targeted strategies that can mitigate these adverse effects.

The interplay between genetic vulnerabilities and environmental factors such as drug exposure continues to underscore the importance of personalized medicine in the management of complex conditions like spinal muscular atrophy and in the broader field of pharmacogenomics.

© 2000-2025 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9


 

Comments

Post a Comment

Popular posts from this blog

Is ME CFS connected to Spinal Muscular Atrophy (SMA)?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. After a 70-year journey filled with misdiagnoses and ineffective treatments, I finally discovered the true cause of my progressive muscle weakness. Throughout this time, I endured insults and was labeled lazy because of my inability to walk long distances, climb stairs, or carry heavy loads. I couldn’t ride a bike because I couldn’t sit on the saddle, and my school performance suffered due to struggles in sports. Instead of support, my parents urged me to work harder to strengthen my muscles, and doctors advised me to exerc...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more